IPO Premiums
IPO calendar
EPEARUMListed

Earum Pharmaceuticals Limited

Fixed Price IPO · BSE

Price band
₹36 - ₹36
Lot size
3,000 shares
Issue amount
₹7 cr
Total subscription
0×
Current priceUnavailable
Listing price ₹36
Watch live price ↗
Opens
21 Jun 2019
Closes
26 Jun 2019
Allotment
1 Jul 2019
Listing
4 Jul 2019

Offer at a glance

Issue overview

Issue size
18,48,000 shares
Face value
₹10 per share
Minimum investment
₹1,08,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,08,000
Issue type
Fixed Price IPO
Shares before issue
43,19,910
Shares after issue
61,67,910

Lot sizes

CategoryLotsSharesAmount
RETAIL13,000₹1,08,000
HNI26,000₹2,16,000

Share reservation

Market Maker5.19%
HNI47.4%
RETAIL47.4%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
01,0002,0003,0004,000Mar-16 · Revenue: 1,856.66Mar-16 · Profit after tax: 9.76Mar-16Dec-17 · Revenue: 2,333.95Dec-17 · Profit after tax: 15.98Dec-17Mar-18 · Revenue: 3,543.67Mar-18 · Profit after tax: 85.65Mar-18Dec-18 · Revenue: 3,449.85Dec-18 · Profit after tax: 86.51Dec-18
RevenueProfit after tax

Company information

Company profile

Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.

Strengths

  • Wide Product Range: Offers a broad selection of products.
  • Experienced Promoter: Backed by 11+ years of industry experience.
  • Quality Assurance: Maintains high quality standards.

Promoters

Mr. Bhumishth Narendrabhai Patel

Mrs. Payal Bhumishth Patel

Registrar & documents

Lead manager

Hem Securities Limited

Registered office

G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210,

+91-79-48402525

[email protected]Company website ↗

Understanding EARUM IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.